Dr Agarwals Eye Hospital Ltd Stock Analysis

BSE: 526783 | NSE: | Hospital & Healthcare Services | Small Cap

BSE Share Price 27-Jan-2023 18:01
1004.40 -32.95 (-3.18%)

DeciZen - Make an Informed Decision on Dr Agarwals Eye Hsp

Overall Rating
M-Cap below 500cr. High Risk from low Liquidity

1. Quality

2. Valuation

Overvalued

3. Price Trend

Semi Strong

Dr Agarwals Eye Hsp Price Chart

P/E Ratio ( SA) :
15.68
Market Cap :
472.1 Cr.
52-wk low :
545
52-wk high :
1,580
Bole Toh?

1. Is Dr Agarwals Eye Hospital Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Dr Agarwals Eye Hospital Ltd is a good quality company.

2. Is Dr Agarwals Eye Hospital Ltd undervalued or overvalued?

The key valuation ratios of Dr Agarwals Eye Hospital Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Dr Agarwals Eye Hospital Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Dr Agarwals Eye Hospital Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Dr Agarwals Eye Hsp:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Dr Agarwals Eye Hospital Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good

Value Creation

Value Creation Index Colour Code Guide

Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22TTM
ROCE % 13.5%11.6%17.1%5.9%19.7%17.4%23.5%27.2%4.6%31.1%-
Value Creation Index -0.0-0.20.2-0.60.40.20.71.0-0.71.2-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 109113118137149153170176140201254
YoY Gr. Rt. %-3.8%4.9%15.6%8.8%3.2%10.9%3.5%-20.5%43.9%-
Adj EPS 75.512.1-0.116.214.525.328.7-35164.1
YoY Gr. Rt. %--20.7%119.2%-100.8%NA-10.5%74.2%13.3%-110.5%NA-
BVPS (₹) 34.840.450.649.862.674.697119.4116.3166.3212.1
Adj Net Profit 3.12.65.707.66.811.913.5-1.42430
Cash Flow from Ops. 1111.913.717.420.118.625.138.633.956.7-
Debt/CF from Ops. 2.62.321.81.2110.50.60.6-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 7.1%6.3%5.8%43.9%
Adj EPS 24.8%25.7%26.3%NA
BVPS 1921.619.743
Share Price 27.6% 5.8% 53.6% 35.9%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22TTM
Return on Equity % 21.81526.6-0.228.921.229.526.5-2.636.133.9
Op. Profit Mgn % 11.49.412.811.115.215.917.626.921.429.227.6
Net Profit Mgn % 2.92.34.8-05.14.577.7-111.911.8
Debt to Equity 1.81.51.11.30.80.50.50.30.40.4-
Working Cap Days 1101171181141121171241311501030
Cash Conv. Cycle -10-6-13-12-17-22-21-9-13-290

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 33.90%

Net Profit is growing at healthy rate in last 3 years 26.27%

Sales growth is good in last 4 quarters at 38.33%

Sales growth has been subdued in last 3 years 5.77%

Latest Financials - Dr Agarwals Eye Hospital Ltd.

Standalone Consolidated
TTM EPS (₹) 64.1 -
TTM Sales (₹ Cr.) 254 -
BVPS (₹.) 212.1 -
Reserves (₹ Cr.) 95 -
P/BV 4.74 -
PE 15.68 -
From the Market
52 Week Low / High (₹) 545.00 / 1580.00
All Time Low / High (₹) 2.10 / 1580.00
Market Cap (₹ Cr.) 472
Equity (₹ Cr.) 4.7
Face Value (₹) 10
Industry PE 60.4

Management X-Ray of Dr Agarwals Eye Hsp :

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *98.8299.2799.8199.5799.8199.1498.4459.7659.8499.80
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Dr Agarwals Eye Hsp

Adj EPS (Rs.)
Sales (Cr.)
ROE (%)
ROCE (%)

News

Dr Agarwals Eye Hospital Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Dr Agarwals Eye Hsp on 27-Jan-2023 18:01 is : 1,004.4.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 27-Jan-2023 18:01 the market cap of Dr Agarwals Eye Hsp stood at ₹ 472.1.
The latest PE ratio of Dr Agarwals Eye Hsp as of 27-Jan-2023 18:01 is 15.68.
The latest PB ratio of Dr Agarwals Eye Hsp as of 27-Jan-2023 18:01 is 4.74
The 52-week high of Dr Agarwals Eye Hsp is ₹ 1,580 and the 52-week low is ₹ 545.0.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue / sales of Dr Agarwals Eye Hsp is ₹ 254.3 ( Cr.) .

About Dr Agarwals Eye Hospital Ltd

Dr.Agarwal's Eye Hospital has been promoted by Dr.J.Agarwal and his family members in 1994. Though the entire family has been in the profession of providing total eye care solutions for almost five decades prior to this, through various private limited company and partnership firms, owned by the family members. The Hospital has always been at the forefront of every medical advancement in the field of Ophthalmic care in the world and has several firsts to its credit. The Hospital is engaged in conducting continuous training and research and development programs and has over a period, developed an excellent team of highly skilled Ophthalmic specialists and surgeons, to assist in its growth plans.

The Hospital, after notching up an impressive success in TamilNadu, Anthra Pradesh and Rajasthan, is embarking on a major expansion program to increase its footprint to other parts of the country and renovation of its flagship facility at Chennai.

Dr. Agarwal's Eye Hospital is listed as 'A Major Eye Centre of the World' by The International Congress of Ophthalmology

Services offered by the company:

  • Intralase Surgery
  • Zyoptix / Lasik Laser
  • Customise your Eyes
  • Cataract Surgery
  • Phaco / Zyoptix Professional

Achievements/ recognition:-

1997:Prof.Amar Agarwal awarded at Coimbatore on 17/08/1997 for the CME conference speaking on lasik laser.

1998:Siva Reddy AwardProf.Amar Agarwal awarded at trichur-30.08.98- by the kerala state oph­thalmic conference for the best paper award- on favit- a new technique to remove dropped nuclei.

2003:Sandeep Wagh Gold MedalProf.Amar Agarwal awarded BY Pune Opthalmic Society and national institute of Opthalmology for his invention of PHAKONIT at Pune on 24th Aug 2003.

L V Pasricha Gold MedalProf. Amar Agarwal awarded by Haryana Opthalmic academy at the 18th anual conference at Haryana Opthalmic conference,Karnal on 25th May 2003 by Hon'ble shri.I D Swami, Minister of state of Home Affairs for the invention of Phakonit Technique.

2005:Outstanding Achievement AwardProf.Amar Agarwal awarded by Bombay ophthalmological association for his invention of microphakonit.This award was presented to him during their annual conference held from 4-6 November 2005 at Mumbai.

2006:Padmabushan Award Prof.Dr.J.Agarwal Receiving Padmabushan award from Hon'ble Dr.J.Abdul Kalam,President of India.

Rajiv Gandhi / G K Moopanar AwardProf.Amar Agarwal awarded by hon'ble union minister of state Mr.G.K.Vasan for his invention of mocrophanpkit.This award was presented to him during a meeting held on 26th aug.2006 at Chennai.

2007:Champion of Humanity AwardProf.Amar Agarwal awarded by Hindustan chamber of commerce for his contribution towards community ophthalmology.  This was presented to him by mr.vijaikumar bafna, president – Hindustan chamber of commerce on 2nd November 2007 at Chennai.

2008:Gold MedalProf.Amar Agarwal awarded the GOLD MEDAL by Bombay ophthalmic association at Mumbai on 20th September 2008.  This was given to him for his new innovation – glued iol.

Scientific Innovation AwardProf. Amar Agarwal awarded by the south Asian academy of opthalmology congress at Delhi on 23rd August 2008. This was awarded to him for his innovations in opthalmology.

Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now